DRUG · Unmapped registry intervention
ALKS 5461
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study
NCT02218008
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Alkermes, Inc.lead sponsor
Mapped research locations
BerlinGermany2San JuanPuerto Rico2New YorkNew York, United States1Los AngelesCalifornia, United States1St LouisMissouri, United States1SeattleWashington, United States1BirminghamAlabama, United States1PortlandOregon, United States1MemphisTennessee, United States1SpokaneWashington, United States1Colorado SpringsColorado, United States1HanoverGermany1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02218008 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.